ASX:CTE Cryosite (CTE) Stock Price, News & Analysis → Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad) Free CTE Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume418 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend Yield9.42%Price TargetN/A Stock AnalysisStock Analysis Get Cryosite alerts: Email Address Ad AltimetrySecret Bull Market Starts in This Unusual Sector"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch. Click for my No. 1 investment, all free of charge, click here. About Cryosite Stock (ASX:CTE)Cryosite Limited offers outsourced clinical trials logistic services in Australia. It operates through two segments, Clinical Trials and Biological Services Logistics, and Cord Blood and Tissues Storage. The Clinical Trials and Biological Services Logistics segment provides specialist temperature-controlled storage, sourcing, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns and biological, as well as logistics services to the clinical trials, research, and pharmaceutical industries. The Cord Blood and Tissues Storage segment offers long term storage solutions for cord blood and tissue samples. It serves research, medical, pharmaceutical, and biotechnology industries. The company was incorporated in 1999 and is based in South Granville, Australia.Read More Ad AltimetrySecret Bull Market Starts in This Unusual Sector"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch. Click for my No. 1 investment, all free of charge, click here. CTE Stock News HeadlinesMarch 21, 2024 | finance.yahoo.comHere's Why Cryosite (ASX:CTE) Has Caught The Eye Of InvestorsFebruary 23, 2024 | finance.yahoo.comA Look At The Fair Value Of Cryosite Limited (ASX:CTE)April 19, 2024 | Crypto 101 Media (Ad)SHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. December 29, 2023 | uk.finance.yahoo.comNon Executive Director of Cryosite Andrew Kroger Buys 12% More SharesDecember 24, 2023 | finance.yahoo.comIs Weakness In Cryosite Limited (ASX:CTE) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?August 25, 2023 | finance.yahoo.comCryosite Full Year 2023 Earnings: EPS: AU$0.029 (vs AU$0.028 in FY 2022)July 16, 2023 | finance.yahoo.comCryosite Limited (ASX:CTE) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?July 15, 2023 | sports.yahoo.comCTE diagnosed in a female professional athlete for the first timeApril 19, 2024 | Crypto 101 Media (Ad)SHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. June 17, 2023 | abcnews.go.comHenri 'Pocket Rocket' Richard, 11-time winner of Stanley Cup, diagnosed with CTE after death in 2020June 17, 2023 | cnn.comExperts say influential group’s guidance on CTE is too weakJune 3, 2023 | finance.yahoo.comInsiders' AU$2.3m Investments In Red Following Cryosite's AU$10m Dip In Market ValueMay 5, 2023 | usnews.comWeslaco 21st Century Cte Early College High SchoolApril 18, 2023 | usatoday.comLouisville bank gunman's brain to be tested for CTE, lawyer says after shooting killed 5 peopleApril 1, 2023 | dailymail.co.ukThe Old Man and the CTE? Did the disease that haunts NFL lead Ernest Hemingway to suicide at 61?March 3, 2023 | au.finance.yahoo.comCryosite Limited (CTE.AX)February 18, 2023 | nj.comFamily of recently-deceased ex-NFL star donates his brain to CTE studyFebruary 6, 2023 | finance.yahoo.comAre Robust Financials Driving The Recent Rally In Cryosite Limited's (ASX:CTE) Stock?December 24, 2022 | nz.finance.yahoo.comMark Kerr of Cryosite Limited (ASX:CTE) Just Spent AU$582k On SharesAugust 26, 2022 | nz.finance.yahoo.comIs Cryosite Limited's (ASX:CTE) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?August 18, 2022 | wsj.comCryosite Ltd.August 9, 2022 | reuters.comCTE.AX - Cryosite Limited | Stock Price & Latest News | ReutersAugust 5, 2022 | nz.finance.yahoo.comStock Bulls Defy Bond Pessimism With Visions of Soft LandingAugust 3, 2022 | finance.yahoo.comIs Now The Time To Put Cryosite (ASX:CTE) On Your Watchlist?June 3, 2022 | afr.comCryosite LimitedMay 25, 2022 | msn.comASX Small Cap Lunch Wrap: Who can spot the elephant in the room today?April 28, 2022 | finance.yahoo.comA Cryosite Limited (ASX:CTE) insider increased their holdings by 11% last yearSee More Headlines Receive CTE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cryosite and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Diagnostics & Research Sub-IndustryN/A Current SymbolASX:CTE CUSIPN/A CIKN/A Webwww.cryosite.com Phone61 2 8865 2000FaxN/AEmployees25Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)A$0.03 Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$1.58 million Net Margins12.49% Pretax MarginN/A Return on Equity63.71% Return on Assets5.17% Debt Debt-to-Equity Ratio87.26 Current Ratio2.32 Quick Ratio1.76 Sales & Book Value Annual Sales$12.62 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow0.55 Book ValueA$0.06 per share Price / BookN/AMiscellaneous Outstanding Shares48,810,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta0.53 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report Key ExecutivesMs. Jane HaoChief Financial OfficerMr. Jon StearnsOperations ManagerMs. Alicia SteelChief Quality OfficerMr. Dray AndreaCompany SecretaryKey CompetitorsANGLEOTCMKTS:ANPCYAustralian Clinical LabsASX:ACLBARD1 Life SciencesASX:BD1BCAL DiagnosticsASX:BDXbioAffinity TechnologiesNASDAQ:BIAFWView All CompetitorsInsidersAndrew KrogerSold 500,000 sharesTotal: $300,000.00 ($0.60/share) CTE Stock Analysis - Frequently Asked Questions Is Cryosite a good dividend stock? Cryosite (ASX:CTE) pays an annual dividend of A$0.07 per share and currently has a dividend yield of 9.42%. CTE has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 233.33%. Payout ratios above 75% are not desirable because they may not be sustainable. Read our dividend analysis for CTE. This page (ASX:CTE) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTIDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsSHOCKING Crypto Leak…Crypto 101 MediaThe #1 Crypto for 2024InvestorPlaceHow Biden has already won 2024Porter & CompanyTop 5 AI Stocks to Buy for 2024Market Moving TrendsUrgent alert: open this for a huge profit potentialTimothy Sykes Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cryosite Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.